Results for:(192 found)
Mar 8, 2013 10:17AM on Top StocksBy Stock Traders Daily

Patent expirations are contributing to M&A fever in the biotech sector.

Mar 6, 2013 11:59AM on Top StocksBy TheStreet Staff

As it strives to increase its product pipeline, the drug company could make a takeover bid -- or entertain a takeover offer.

Mar 4, 2013 10:12AM on Top StocksBy Jim Cramer

These aren't ever going to be crushed, but could certainly stumble.

Feb 26, 2013 11:36AM on Top StocksBy StreetAuthority

Both stocks soared after the legendary investor dumped them. Did he make the right call?

Feb 13, 2013 12:14PM on Top StocksBy Minyanville.com

The classification of ibrutinib as a breakthrough therapy could mean speedy approval by the agency.

Tags: JNJPCYC
Feb 13, 2013 12:07PM on Top StocksBy InvestorPlace

Expecting a turn for the worse? Here's how to get defensive.

Feb 8, 2013 10:03AM on Top StocksBy TheStockAdvisors

These quality stocks were selected based on historic patterns of payout and valuation.

Feb 7, 2013 1:01PM on Top StocksBy MSN Money Partner

Yahoo is upgraded to 'buy,' and Johnson & Johnson is downgraded to 'underperform.'

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.